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Impact of Transcatheter Closure of Atrial Septal
Defects in Pediatric Patients on Body Weight
Mao-Hung Lo,1 Chien-Fu Huang,1 Sheung-Fat Ko,2 Shao-Ju Chien,1 Ying-Jui Lin,1
I-Chun Lin,1 Chi-Di Liang1*
Background/Purpose: Pediatric patients with atrial septal defect (ASD) may have failure to thrive. This
study aimed to investigate body weight changes in pediatric patients after transcatheter closure of ASD.
Methods: From June 2003 to September 2008, we enrolled 60 pediatric patients who underwent trans-
catheter closure of ASD. Changes in body weight percentile, heart rate, and resolution of right ventricular
hypertrophy were compared before and after ASD closure. Patients were divided into two groups accord-
ing to initial weight percentile: group A, < 50th percentile (n = 39) and group B, ≥ 50th percentile (n = 21).
Echocardiography and routine weight measurements were performed before the procedure and at 3, 6,
and 12 months during follow-up. Clinical presentations, laboratory data, and outcomes were measured.
Results: Increased body weight percentile (41 ± 4 vs. 48 ± 4, p < 0.01), lower heart rate (100 ± 2 beats/min
vs. 89 ± 2 beats/min, p < 0.01), and resolution of right ventricular hypertrophy (59/60 vs. 1/60, p < 0.01)
were achieved after ASD closure at the 12-month follow-up. Patients in group A were significantly younger
(4.6 ± 0.5 years vs. 7.0 ± 0.9 years, p = 0.016), had a higher pulmonary/systemic blood flow ratio (2.2 ± 0.1
vs. 1.8 ± 0.1, p = 0.044), a larger ratio of ASD diameter/body surface area (25.0 ± 1.4 vs. 16.4 ± 1.9, p < 0.01),
and higher percentage of weight gain increase ≥ 5 percentile compared with patients in group B (22/39 vs.
6/21, p = 0.039).
Conclusion: Transcatheter closure of ASD positively affects weight gain. An increase of 7 percentile weight
was observed at 1 year of follow-up. Patients with a younger age, higher pulmonary/systemic blood flow
ratio, and a larger ratio of ASD diameter/body surface area may have better weight gain after ASD closure.
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Atrial septal defect (ASD) is a common congenital
heart disease. Most pediatric patients are asymp-
tomatic, but patients with large ASD or significant
left to right shunt may have failure to thrive.1,2
Improvement in body weight after surgical repair
of ASD has been reported.3,4 With improved
catheterization techniques, transcatheter closure
of ASD has become an alternative procedure to
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surgical closure.5,6 There are only a few reports
assessing the outcome of weight change after trans-
catheter closure of ASD.3,7 The objective of this
study was to investigate the impact of transcatheter
closure of ASD on body weight gain in pediatric
patients.
Patients and Methods
From June 2003 to September 2008, 60 children
(16 boys and 44 girls) who underwent trans-
catheter closure of ASD with an Amplatzer septal
occluder (ASO) (AGA Medical Corp., Golden
Valley, MN, USA) were enrolled. The study was
retrospective and the data collection was approved
by the Institutional Review Board of Chang Gung
Memorial Hospital. Among these patients, all ex-
cept one patient had right heart dilatation. Five
patients had dyspnea on exercise. Four patients
had other associated cardiac anomalies, including
three with pulmonary valvular stenosis and one
patent ductus arteriosus. Among patients with pul-
monary stenosis, one received balloon angioplasty
at infancy because of critical stenosis, and the other
two had conservative treatment because their pres-
sure gradient was less than 30 mmHg. The patient
with patent ductus arteriosus received a Gianturco
coil implantation in the same procedure.
The indication for closure was an age over 
2 years and less than 18 years, the presence of right
ventricular hypertrophy (RVH) and/or a ratio of
pulmonary blood flow to systemic blood flow
(Qp/Qs ratio) ≥ 1.5. RVH was determined by elec-
trocardiogram (ECG) and echocardiogram.8,9 The
diagnosis of RVH by ECG fulfilled at least three
of the following criteria: right axis deviation, tall
P waves (> 2.5 mm), an rsR pattern in the right
precordial leads with the second R wave taller
than the initial one, a qR pattern in the right pre-
cordial leads, age-corrected increased voltage of
the R wave in lead V1, increased voltage of the 
S wave in leads V5–V6, and a positive T wave in
lead V1 between the ages of 6 days and 6 years.
On echocardiographic assessment, RVH was di-
agnosed by the demonstration of paradoxical
motion of the interventricular septum on an 
M-mode study and/or the presence of a larger right
ventricular volume than the left ventricular coun-
terpart, as seen on the apical four-chamber view of
a two-dimensional echocardiogram. After device
closure of ASD, the right ventricular volume was
considered normal when there was no paradoxical
motion of the interventricular septum as observed
from the M-mode study, and regressive change of
the right ventricle with ventricular volume equal to
or less than that of the left ventricle as seen on the
apical four-chamber view of a two-dimensional
echocardiogram. Patients with chromosomal ab-
normalities, congestive heart failure, severe gas-
trointestinal tract malformation, or diseases that
potentially caused failure to thrive were excluded.
The procedure was performed under general
anesthesia. The morphological characteristics of
the defect and size were evaluated by transesopha-
geal echocardiography in most of our cases and a
cylindrical Amplatzer sizing balloon (AGA Medical
Corp.) was used in some of the cases.10 Echocar-
diographic study was performed using the Philips
SONOS 7500 system (Philips, Andover, MA, USA).
Right and left heart catheterization was performed
and pressures were determined with a Berman an-
giocatheter (Arrow International, Mt. Holly, NJ,
USA). Pulmonary and systemic flows were deter-
mined by the Fick method.
Since weight gain naturally increases as children
grow up, we adopted body weight percentile as a
parameter to investigate the effect of ASD closure
on weight changes. The World Health Organization
(WHO) child growth standard database (www.
who.int/childgrowth/) depicts normal growth un-
der optimal environmental conditions and can
be used to assess children everywhere, regardless
of ethnicity, socio-economic status, and type of
feeding.11 Therefore, WHO charts were adopted
in this study, and the body weight percentile was
calculated via the least mean square method.12
The size of the ASD was unable to be used as
a parameter to evaluate the effect on weight gain
because it was variable depending on the children’s
age and body mass.13 Therefore, an ASD size/body
surface area (BSA) ratio was applied for evaluation
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of the effect on body weight gain. The BSA was
calculated by means of the following formula:14
BSA = /60
In most patients, heart rate was recorded by
using a complete 12-lead surface ECG with the pa-
tients in a quiet condition after resting for at least
5 minutes. In young children or patients with poor
cooperation, heart rate was assessed when the pa-
tients were sleeping. Among these 60 patients,
changes in body weight percentile, heart rate, and
the resolution of RVH were compared before and
after ASD closure. In addition, the patients were di-
vided into two groups according to initial weight
percentile: group A, < 50th percentile; group B,
≥ 50th percentile. Echocardiography, ECG, and
weight measurements were performed before the
procedure and at the 3rd, 6th, and 12th months
during follow-up. Clinical presentations, labora-
tory data, and outcomes were compared. Com-
parisons between these two groups were made
regarding their sex, age, heart rate, mean pulmo-
nary artery pressure, Qp/Qs ratio, ASD size, and
ratio of ASD diameter/BSA.
Statistical analysis
Data are expressed as mean ± standard error. Com-
parisons of body weight percentile and heart rate
before and after the procedure were performed
with a paired Student t test. A satisfying outcome
was an improvement in weight by over 5 percen-
tile at 12 months. Comparisons of clinical param-
eters between the two groups were performed
with an unpaired Student t test, χ2 test, or Fisher’s
exact test, as appropriate. A p value of < 0.05 was
considered statistically significant.
Results
The median age of the 60 children was 4.1 years
(range, 2–17.2 years). The clinical presentations
are shown in Table 1. Increased body weight per-
centile (41±4 vs. 48±4, p<0.01), a lower heart rate
(100 ± 2 beats/min vs. 89 ± 2 beats/min, p < 0.01),
and resolution of RVH (59/60 vs. 1/60, p < 0.01)
were achieved after ASD closure at the 12-month
follow-up. In addition, resolution of RVH was
detected by echocardiography at the 6-month
follow-up in all patients, except for one patient.
The only patient who had persistent right heart
dilatation was a 6-year-old boy who had critical
pulmonary stenosis. Follow-up echocardiography
showed no residual stenosis but a moderate degree
of pulmonary regurgitation, which contributed to
persistent right heart volume overload.
There were 39 patients in group A and 21 pa-
tients in group B. The clinical manifestations 
are shown in Table 2. There were no statistically
significant differences between the two groups
regarding sex distribution, heart rate, mean pul-
monary artery pressure, ASD size, and the pres-
ence of residual shunt at the 12-month follow-up.
Patients in group A were significantly younger
(4.6 ± 0.5 years vs. 7.0 ± 0.9 years, p = 0.016), had
a higher pulmonary/systemic blood flow ratio
(2.2 ± 0.1 vs. 1.8 ± 0.1, p = 0.044) and a larger ratio
of ASD diameter/BSA (25 ± 1.4 vs. 16.4 ± 1.9, p <
0.01) compared with patients in group B. In ad-
dition, a higher percentage of weight gain increase
≥ 5 percentile was observed in group A patients
compared with that in group B (22/39 vs. 6/21,
p=0.039). During follow-up, the mean weight gain
was 1.7 kg, 2.0 kg, and 3.4 kg at the 3rd, 6th, and
height (cm) × weight (kg)
Table 1. Clinical presentations of atrial septal defect patients before and after closure
Before closure
Third month Sixth month Twelfth month 
after closure after closure after closure
Heart rate (beats/min) 100 ± 2 93 ± 2* 92 ± 2* 89 ± 2*
Presence of RVH 59/60 6/60* 1/60* 1/60*
BW (kg) 20.7 ± 1.6 22.4 ± 1.9* 22.7 ± 1.8* 24.1 ± 1.8*
BW percentile 41 ± 4 46 ± 4* 48 ± 4* 48 ± 4*
*p < 0.05. BW = body weight; RVH = right ventricular hypertrophy.
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12th months of follow-up, respectively. Among the
60 patients, 28 (22 in group A and 6 in group B)
demonstrated a body weight increment ≥ 5 per-
centile 1 year after transcatheter closure of ASD.
Patients in group A had weight gain increments
of 4, 8, and 11 percentile at the 3rd, 6th, and 12th
months of follow-up, respectively. Weight im-
provement by 5 percentile was achieved at the 
6th and 12th months of follow-up in patients of
group A only (Table 3). This finding indicates
that thinner children have a better improvement
in weight gain.
Discussion
ASD is a structural defect between the right and
left atria. Although ASD is often asymptomatic in
childhood, it may potentially cause heart failure
or failure to thrive.15,16 After early ASD closure by
surgery or by transcatheter device implantation,
good improvement in right ventricular and right
atrial volume overload can be achieved.5,17,18 In
our study, there was no significant difference in
ASD size between the two groups. However, pa-
tients in group A had a larger ASD/BSA ratio than
patients in group B. Right heart volume resolution
has been reported as early as 3 to 6 months after
device closure.5,19 In our study, right heart dila-
tation had regressed to normal in most children
during 6 months of follow-up.
Previous studies have concluded that body
weight gain improves after surgical repair of
ASD.3,4 Rhee et al reported improvement in
growth after surgical or transcatheter device clo-
sure of an ASD in asymptomatic children in the
lower 16th percentile for height or weight.3 Fraisse
et al observed that transcatheter closure of ASD
in children weighing 15 kg or less with retarded
growth tends to recover within 1 year of closure.7
In contrast, our study applied body weight per-
centile as a parameter to investigate the effect of
body weight change after transcatheter closure of
ASD. Our results demonstrated that transcatheter
closure of ASD has a positive effect on weight gain,
especially for children whose weight was < 50th
percentile, were a younger age, had a higher Qp/Qs
ratio, and had a larger ratio of ASD/BSA.
Failure to thrive is a very complex condition
in children. The pathophysiology includes pre-
maturity, genetic factors, congenital anomalies
or syndrome, anemia, decreased immunologic
Table 2. Clinical manifestations of patients with atrial septal defect
Group A (n = 39) Group B (n = 21) p
Sex (male:female) 10:29 6:15 0.807
Age (yr) 4.6 ± 0.5 7.0 ± 0.9 0.016*
Initial heart rate (beats/min) 103 ± 3 95 ± 3 0.083
Mean pulmonary artery pressure (mmHg) 18.6 ± 0.7 17.4 ± 0.8 0.251
Qp/Qs ratio 2.2 ± 0.1 1.8 ± 0.1 0.044*
ASD size (mm) 16.1 ± 0.8 14.5 ± 1.5 0.318
ASD size/BSA ratio 25.0 ± 1.4 16.4 ± 1.9 < 0.01*
Weight increased ≥ 5 percentile at the 12th month 22/39 6/21 0.039*
Residual shunt after 12 months follow-up 2/39 0/21 0.537
*p < 0.05. Group A = weight < 50th percentile; Group B = weight ≥ 50th percentile; ASD = atrial septal defect; BSA = body surface area;
Qp/Qs = ratio of pulmonary blood flow to systemic blood flow.
Table 3. Weight percentile increased after atrial
septal defect closure
Group A Group B
p
(n = 39) (n = 21)
3rd month 4 ± 2 3 ± 2 0.635
6th month 8 ± 2 3 ± 2 0.145
12th month 11 ± 3 0 ± 3 0.023*
*p < 0.05. Group A = weight < 50th percentile; Group B = weight ≥
50th percentile.
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function, increased metabolic rate, maldigestion,
malabsorption, or endocrine disorders.20–23 There-
fore, we excluded such patients from the study.
In addition, constitutional status or other factors
such as food intake, nutrition and activities could
also be important factors affecting body weight
gain in these children. In general, weight gain
improves in patients after transcatheter closure of
ASD. However, in our study, there were 17 patients
in group A whose weight increase was < 5 per-
centile at the 1-year follow-up. Such poor body
weight gain might be due to poor caloric intake
or slim condition of the patients.
Our study was limited by the absence of a con-
trol group (ASD patients without closure). How-
ever, recruitment of such a control group was
difficult. More importantly, it is not ethical without
applying appropriate management for ASD patients
with right heart failure. In addition, the present
study aimed at assessing the effect of transcatheter
closure of ASD in the improvement of body weight.
Therefore, other biochemical markers that might af-
fect body weight gain, such as prealbumin, insulin-
like growth factors or growth hormone, were not
included. The results of this study suggest that
patients with ASD and poor weight gain may have
a potential benefit after early transcatheter closure.
In summary, transcatheter closure of ASD has
a positive effect on weight gain. An increase of 
7 percentile weight is found in children at the 
1-year follow-up. Patients who have a younger age,
a higher pulmonary/systemic blood flow ratio,
and a larger ratio of ASD diameter/BSA may have
better weight gain after ASD closure.
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